Federal Register / Vol. 87, No. 3 / Wednesday, January 5, 2022 / Notices 463 

TABLE—ANNUALIZED BURDEN HOUR—Continued 

45 CFR part 46—HHS consultation process provision Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Total .......................................................................................................... ........................ ........................ ........................ 10 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2021–28566 Filed 1–4–22; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Physician-Focused Payment Model 

Technical Advisory Committee; 

Meetings 

ACTION: Notice of meetings. 

SUMMARY: This notice announces the 

2022 meetings of the Physician-Focused 

Payment Model Technical Advisory 

Committee (PTAC). These meetings 

include deliberation and voting on 

proposals for physician-focused 

payment models (PFPMs) submitted by 

individuals and stakeholder entities and 

may include discussions on topics 

related to current or previously 

submitted PFPMs. All meetings are 

open to the public. 

DATES: The 2022 PTAC meetings will 

occur on the following dates: 

• Monday–Tuesday, March 7–8, 2022, 

from 10:00 a.m. to 3:00 p.m. ET 

• Tuesday–Wednesday, June 7–8, 2022, 

from 9:00 a.m. to 5:00 p.m. ET 

• Monday–Tuesday, September 19–20, 

2022, from 9:00 a.m. to 5:00 p.m. ET 

• Thursday–Friday, December 8–9, 

2022, from 9:00 a.m. to 5:00 p.m. ET 

Please note that times are subject to 

change. If the times change, the ASPE 

PTAC website will be updated (https:// 

aspe.hhs.gov/ptac-physician-focusedpayment-model-technical-advisorycommittee) and registrants will be 

notified directly via email. 

ADDRESSES: All PTAC meetings will be 

held virtually or in the Great Hall of the 

Hubert H. Humphrey Building, 200 

Independence Avenue SW, Washington, 

DC 20201. 

FOR FURTHER INFORMATION CONTACT: Lisa 

Shats, Designated Federal Officer at 

Lisa.Shats@hhs.gov (202) 875–0938. 

SUPPLEMENTARY INFORMATION: 

Agenda and Comments. PTAC will 

hear presentations on proposed PFPMs 

that have been submitted by individuals 

and stakeholder entities and/or 

discussion on topics related to current 

or previously submitted PFPMs. 

Regarding proposed PFPMs, following 

each presentation, PTAC will deliberate 

on the proposed PFPM. If PTAC 

completes its deliberation, PTAC will 

vote on the extent to which the 

proposed PFPM meets criteria 

established by the Secretary of Health 

and Human Services and on an overall 

recommendation to the Secretary. Time 

will be allocated for public comments. 

The agenda and other documents will 

be posted on the PTAC section of the 

ASPE website, https://aspe.hhs.gov/ 

ptac-physician-focused-payment-modeltechnical-advisory-committee, prior to 

the meeting. The agenda is subject to 

change. If the agenda does change, 

registrants will be notified directly via 

email, the website will be updated, and 

notification will be sent out through the 

PTAC email listserv (https://list.nih.gov/ 

cgi-bin/wa.exe?A0=PTAC to subscribe). 

Meeting Attendance. These meetings 

are open to the public and may be 

hosted in-person or virtually. We intend 

that in-person meetings will be held in 

the Great Hall of the Hubert H. 

Humphrey Building. The public may 

attend in person, when feasible, via 

conference call, or view the meeting via 

livestream at www.hhs.gov/live. The 

conference call dial-in information will 

be sent to registrants prior to the 

meeting. Space may be limited, and 

registration is preferred. For meetings 

that are held virtually, the public may 

attend via WebEx link (including a dialin only option) or view the meeting via 

livestream at www.hhs.gov/live. 

Registration may be completed online at 

http://www.cvent.com/d/gbq2tg. Name, 

organization name, and email address 

are submitted when registering. 

Registrants will receive a confirmation 

email shortly after completing the 

registration process. 

Special Accommodations. If sign 

language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact 

ASPE PTAC staff, no later than two 

weeks prior to the scheduled meeting. 

Please submit your requests by email to 

PTAC@hhs.gov. 

Authority. 42 U.S.C 1395(ee); Section 

101(e)(1) of the Medicare Access and 

CHIP Reauthorization Act of 2015; 

Section 51003(b) of the Bipartisan 

Budget Act of 2018. 

PTAC is governed by provisions of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C app.), which sets 

forth standards for the formation and 

use of federal advisory committees. 

Dated: December 30, 2021. 

Rebecca Haffajee, 

Acting Assistant Secretary for Planning and 

Evaluation, Principal Deputy. 

[FR Doc. 2021–28578 Filed 1–4–22; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Small Business Innovation 

Research (SBIR) Phase II Program Contract 

Solicitation (PHS 2020–1) NIAID Research 

Topic No. 85 Phase II Adaptable RNA-based 

antibody platform for protection against 

contemporary/emerging human 

enteroviruses. 

Date: January 26, 2022. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E70, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Mohammed S. Aiyegbo, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 


TKELLEY on DSK125TN23PROD with NOTICE 
464 Federal Register / Vol. 87, No. 3 / Wednesday, January 5, 2022 / Notices 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E70, 

Rockville, MD 20852, (301) 761–7106, 

mohammed.aiyegbo@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 29, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–28530 Filed 1–4–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; SBIR PHS 2022–1: Digital 

Tools Against Misinformation About 

Infectious Disease Treatments and Vaccines 

(Topic 112). 

Date: January 26–28, 2022. 

Time: 9:30 a.m. to 12:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Patricia A. Gonzales 

Hurtado, Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71A, 

Rockville, MD 20852, 240–627–3556, 

Patricia.Gonzales@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; PHS–2022–1: Digital Tools 

Against Misinformation About Infectious 

Disease Treatments and Vaccines (Topic 

112)—Phase II. 

Date: January 28, 2022. 

Time: 12:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Patricia A. Gonzales 

Hurtado, Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71A, 

Rockville, MD 20852, 240–627–3556, 

Patricia.Gonzales@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 29, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–28532 Filed 1–4–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; HHS–NIH–CDC–SBIR PHS 

2022–1 Phase I: Point of Care (POC) 

Diagnostics for Antimicrobial Resistant 

(AMR) Enteric Bacterial and Parasitic 

Pathogens (Topic 110). 

Date: January 28, 2022. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals.. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E61, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Ann Marie M. Brighenti, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E61, 

Rockville, MD 20852, 301–761–3100, 

AnnMarie.Cruz@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; HHS–NIH–CDC–SBIR PHS 

2022–1 Phase II: Point of Care (POC) 

Diagnostics for Antimicrobial Resistant 

(AMR) Enteric Bacterial and Parasitic 

Pathogens (Topic 110). 

Date: January 28, 2022. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E61, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Ann Marie M. Brighenti, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E61, 

Rockville, MD 20852, 301–761–3100, 

AnnMarie.Cruz@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 29, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–28531 Filed 1–4–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Lung Cellular, Molecular, and 

Immunobiology Study Section. 

Date: February 1–2, 2022. 


TKELLEY on DSK125TN23PROD with NOTICE